SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,515.43 362.57
( 0.48%)

Global Indices

Nasdaq

53,682.77 599.82
(1.13%)

Dow Jones

7,765.55 77.95
(1.01%)

Hang Seng

65,002.68 788.20
(1.23%)

Nikkei 225

10,828.70 -2.82
(-0.03%)

Forex

USD-INR

94.73 -0.22
(-0.23%)

EUR-INR

109.71 -0.40
(-0.36%)

GBP-INR

127.83 -0.65
(-0.50%)

JPY-INR

0.59 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Rubicon Research Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

544578

INE506V01022

81.7556682

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

RUBICON

124.76

29367.84

EPS(TTM)

Face Value()

Div & Yield %

14.22

0.08

Back

mercury ev tech ltd

KSB consolidated net profit declines 22.87% in the March 2026 quarter

Apr 30,2026

Net profit of KSB declined 22.87% to Rs 39.80 crore in the quarter ended March 2026 as against Rs 51.60 crore during the previous quarter ended March 2025. Sales rose 0.99% to Rs 601.30 crore in the quarter ended March 2026 as against Rs 595.40 crore during the previous quarter ended March 2025.

Particulars	Quarter Ended
	Mar. 2026	Mar. 2025	% Var.
Sales	601.30	595.40	1
OPM %	8.45	11.37	-
PBDT	67.80	82.90	-18
PBT	53.30	69.00	-23
NP	39.80	51.60	-23

76,515.43 362.57 ( 0.48%)

53,682.77 599.82 (1.13%)

7,765.55 77.95 (1.01%)

65,002.68 788.20 (1.23%)

10,828.70 -2.82 (-0.03%)

94.73 -0.22 (-0.23%)

109.71 -0.40 (-0.36%)

127.83 -0.65 (-0.50%)

0.59 0.00 (0.14%)